ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 89 filers reported holding ALLOVIR INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $660,336 | -39.8% | 307,133 | -4.8% | 0.00% | – |
| Q2 2023 | $1,097,272 | +72.4% | 322,727 | +99.8% | 0.00% | – |
| Q1 2023 | $636,464 | -42.6% | 161,539 | -25.3% | 0.00% | – |
| Q4 2022 | $1,108,742 | -18.9% | 216,129 | +24.7% | 0.00% | – |
| Q3 2022 | $1,367,000 | +53.3% | 173,331 | -24.2% | 0.00% | – |
| Q2 2022 | $892,000 | +22.2% | 228,667 | +111.5% | 0.00% | – |
| Q1 2022 | $730,000 | -39.1% | 108,104 | +16.7% | 0.00% | – |
| Q4 2021 | $1,199,000 | -53.8% | 92,609 | -10.6% | 0.00% | -100.0% |
| Q3 2021 | $2,597,000 | +66.9% | 103,643 | +31.5% | 0.00% | – |
| Q2 2021 | $1,556,000 | -76.3% | 78,841 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $6,559,000 | +463.5% | 280,310 | +826.0% | 0.00% | – |
| Q4 2020 | $1,164,000 | -32.2% | 30,271 | -51.5% | 0.00% | – |
| Q3 2020 | $1,716,000 | – | 62,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |